The opioid crisis has affected a substantial number of pregnant women in the United States, with the number of pregnant women with an opioid use disorder (OUD) diagnosis at delivery quadrupling from 1999 to 2014
1 and prenatal opioid exposure resulting in a 7-fold increase in neonatal abstinence syndrome (NAS) from 2000 to 2014.
2,3 Neonatal intensive care unit admissions for NAS increased nearly 4-fold between 2004 and 2013,
4 and in some hospitals, NAS accounts for approximately half of all neonatal intensive care unit days.
5 There is substantial state-to-state variation in NAS rates,
6,7 as well as county-level variation associated with structural factors, such as higher rates of long-term unemployment and less access to mental health care practitioners.
8 Neonates with NAS often require prolonged and costly hospitalizations,
9 with total hospital costs for births with NAS exceeding $500 million by 2014.
3